Free Lesson Preview
This is just the beginning
The full CRC track covers 8 courses from study start-up to close-out — the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Free GCP training
Professional tracks
Clinical Research Coordinator
Full course · Safety Reporting and Pharmacovigilance for CRCs
Free Lesson Preview
The full CRC track covers 8 courses from study start-up to close-out — the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Navigate the three regulatory frameworks governing safety reporting -- ICH E6(R3) principles, ICH E2A definitions, and FDA enforcement requirements under 21 CFR 312.
Here is something that confuses nearly every coordinator encountering safety reporting regulations for the first time: there is not one set of rules. There are three. They were developed at different times, by different bodies, for different purposes -- and yet they must be understood together because they govern a single activity: reporting safety events in clinical trials.
ICH E6(R3) tells you what investigators and sponsors are obligated to do. ICH E2A tells you what the terms mean and which categories trigger which reporting pathways. And 21 CFR Part 312 -- the FDA's regulations -- tells you what happens when those obligations carry the force of United States law, complete with specific calendar-day deadlines and enforcement consequences.
If you understand only one of these frameworks, you will have gaps. If you understand all three and -- more importantly -- how they interrelate, you will understand why your protocol's safety reporting section is written the way it is. And that understanding is what separates a coordinator who follows instructions from one who comprehends the system well enough to catch errors before they become compliance failures.
Progress saves itself — finish reading and this lesson completes